Neuren Pharmaceuticals Limited (ASX: NEU)

Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,589	3,178	1,001	475	147	248
Market Cap Growth	75.35%	217.33%	110.88%	222.46%	-40.72%	77.14%
Enterprise Value	1,376	3,092	970	457	138	231
Last Close Price	12.43	24.97	7.95	3.77	1.28	2.48
PE Ratio	13.90	20.23	5442.54	-	-	-
Forward PE	16.07	32.20	19.55	135.13	-	-
PS Ratio	8.21	13.70	64.96	148.54	205.40	501.85
PB Ratio	7.25	15.49	24.08	12.10	6.09	17.94
P/TBV Ratio	12.41	15.49	24.08	12.10	6.09	17.94
P/FCF Ratio	13.30	17.19	279.73	-	-	-
P/OCF Ratio	22.75	17.18	278.25	-	-	-
EV/Sales Ratio	7.11	13.33	62.94	142.84	192.61	466.97
EV/EBITDA Ratio	8.86	15.52	-	-	-	-
EV/EBIT Ratio	8.87	15.52	-	-	-	-
EV/FCF Ratio	11.51	16.72	271.04	-	-	-
Asset Turnover	1.19	1.59	0.37	0.10	0.04	0.02
Quick Ratio	25.42	5.68	24.59	47.58	33.12	25.75
Current Ratio	25.42	5.78	25.77	49.87	33.12	25.75
Return on Equity (ROE)	75.51%	127.30%	0.46%	-24.57%	-48.32%	-56.16%
Return on Assets (ROA)	59.56%	85.52%	-1.10%	-15.83%	-27.98%	-33.73%
Return on Capital (ROIC)	62.43%	100.92%	-1.13%	-16.22%	-28.94%	-35.95%
Earnings Yield	7.19%	4.94%	0.02%	-1.64%	-6.24%	-4.35%
FCF Yield	7.52%	5.82%	0.36%	-2.10%	-5.49%	-4.72%
Buyback Yield / Dilution	-0.15%	-1.44%	-8.76%	-10.71%	-6.88%	-0.42%
Total Shareholder Return	-0.15%	-1.44%	-8.76%	-10.71%	-6.88%	-0.42%

Source: S&P Capital IQ. Standard template. Financial Sources.